The global end-stage renal disease market size was valued at USD 135.87 billion in 2025 and is projected to grow from USD 154.17 billion in 2026 to USD 423.69 billion by 2034, exhibiting a CAGR of 13.47% during the forecast period (2026-2034).

The increasing prevalence of chronic kidney disease, growing diabetic and hypertensive populations, rising demand for renal replacement therapies, and technological advancements in dialysis and transplantation procedures are contributing significantly to market growth. Improvements in healthcare infrastructure and increasing awareness regarding early diagnosis and treatment are further supporting the expansion of the market worldwide.

Key Highlights

• North America held the largest share of the global end-stage renal disease market.
• Asia-Pacific is expected to be the fastest-growing region during the forecast period.
• Based on treatment type, dialysis accounted for the largest market share.
• Home dialysis is anticipated to emerge as the fastest-growing treatment segment during the forecast period.
• Increasing incidence of diabetes and hypertension continues to fuel demand for ESRD therapies.
• Technological advancements in dialysis equipment and renal care services are accelerating market expansion.

Market Dynamics

Driver

The growing burden of chronic kidney disease and the increasing number of patients suffering from diabetes and hypertension are among the major factors driving the end-stage renal disease market. Aging populations and lifestyle-related disorders have significantly increased the demand for dialysis and kidney transplantation procedures across developed and developing countries.

Furthermore, technological innovations in dialysis systems, enhanced reimbursement policies, and rising healthcare expenditure are contributing to the adoption of advanced renal care solutions. Expanding access to healthcare services and increasing awareness programs are also strengthening market growth.

Restraint

Despite favorable growth prospects, the high cost associated with dialysis treatment and kidney transplantation remains a major challenge for patients and healthcare systems. Limited availability of donor organs and complications associated with long-term dialysis treatment also hinder market growth.

Additionally, inadequate healthcare infrastructure and lack of access to specialized nephrology services in several developing regions restrict the widespread adoption of advanced renal disease management solutions.

Opportunity

Increasing investments in home dialysis technologies and wearable artificial kidney devices are creating substantial opportunities for market participants. Rising demand for personalized healthcare and remote patient monitoring solutions is encouraging innovation in renal care.

Moreover, advancements in regenerative medicine, bioengineered kidneys, and artificial organ technologies are expected to open new growth avenues. Strategic collaborations between healthcare providers, biotechnology companies, and medical device manufacturers are likely to further enhance market expansion over the coming years.

Top Market Players

• Fresenius Medical Care AG
• DaVita Inc.
• Baxter International Inc.
• B. Braun SE
• Nipro Corporation
• Medtronic plc
• Asahi Kasei Corporation
• Nikkiso Co., Ltd.
• Toray Medical Co., Ltd.
• Cantel Medical Corporation
• Dialife SA
• Outset Medical Inc.

Market Segmentation

By Treatment Type

• Dialysis
  • Hemodialysis
  • Peritoneal Dialysis
• Kidney Transplantation

By End User

• Hospitals
• Dialysis Centers
• Home Care Settings

Regional Analysis

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Unlock Full Report Insights and Strategic Analysis: https://straitsresearch.com/report/end-stage-renal-disease-market

The report provides detailed analysis of market size, growth drivers, restraints, opportunities, competitive landscape, company profiles, segmentation, and regional outlook to help stakeholders make informed business decisions.

About Us

Straits Research is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights and market research reports.

Contact Us

Email: sales@straitsresearch.com

Tel:
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)